Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › OH › Greenville › NPI 1184621161
Hospital

Wayne Hospital Company

Wayne Hospital Company was paid $9.91M by Medicaid between Jan 2018 and Dec 2024, across 171 billing codes. Its largest line is 99283, emergency room visit (moderate) — 24% of everything it billed.

33Billing provider infoWAYNE HOSPITAL COMPANY
GREENVILLE, OH 45331
33aNPI1184621161assigned 07/05/2005
33bProvider typeCritical Access Hospital
28Total paid$9.91M
24GClaims293,557
24DCodes billed171
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers

Next to other Critical Access Hospital providers in Ohio

Rank by total paid#7 of 26
Median peer was paid$5.33M
This provider vs. median1.9×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

$0$200K$400K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
201832,858$900K
201933,744$884K
202025,101$965K
202132,001$1.05M
202231,838$1.05M
202382,198$2.99M
2024incomplete55,817$2.06M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 24% 20,640 19,137 $2.36M
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 20% 16,407 15,006 $1.99M
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 16% 11,605 10,358 $1.54M
74176 Computed tomography, abdomen and pelvis; without contrast material 5.1% 1,889 1,615 $504K
70450 Computed tomography, head or brain; without contrast material 3.7% 1,584 1,377 $365K
97110 Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion 3.5% 4,216 1,138 $349K
96361 Intravenous infusion, hydration; each additional hour 3.3% 1,155 883 $325K
0241U Neonatal screening for hereditary disorders, genomic sequence analysis panel 2.6% 2,633 2,241 $257K
74177 Computed tomography, abdomen and pelvis; with contrast material 1.9% 718 614 $184K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour 1.8% 1,051 824 $179K
80053 Comprehensive metabolic panel 1.3% 16,093 14,301 $126K
71260 Computed tomography, thorax, diagnostic; with contrast material 1.3% 510 438 $124K
159 more codes
99282 Emergency department visit for the evaluation and management, low to moderate severity 1.2% 963 $119K
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 1.1% 979 $112K
92507 Treatment of speech, language, voice, communication, and/or auditory processing disorder 1.1% 1,301 $106K
93010 Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only <1% 12,740 $77K
G0463 Hospital outpatient clinic visit for assessment and management of a patient <1% 731 $69K
97140 Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) <1% 2,505 $60K
99214 Doctor's office visit, returning patient (more involved) <1% 492 $59K
99281 Emergency department visit for the evaluation and management, self-limited or minor <1% 453 $55K
G0378 Hospital observation service, per hour <1% 898 $50K
96366 Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour <1% 197 $49K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 320 $44K
97530 Therapeutic activities, direct patient contact, each 15 minutes <1% 447 $34K
87491 Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe <1% 915 $34K
97162 <1% 518 $32K
71046 Radiologic examination, chest; 2 views <1% 2,268 $30K
84443 Thyroid stimulating hormone (TSH) <1% 2,152 $28K
80048 Basic metabolic panel (calcium, ionized) <1% 5,464 $27K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 2,348 $27K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 22,589 $26K
87591 Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe <1% 899 $22K
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 121 $22K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 8,964 $21K
71045 Radiologic examination, chest; single view <1% 6,433 $21K
87502 Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets <1% 2,525 $21K
36415 Collection of venous blood by venipuncture <1% 26,414 $21K
88142 <1% 994 $20K
76856 Ultrasound, pelvic (nonobstetric), real time with image documentation; complete <1% 99 $20K
85027 <1% 1,896 $20K
77063 Screening digital breast tomosynthesis, bilateral <1% 453 $18K
87661 Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe <1% 533 $18K
84484 <1% 4,646 $14K
87086 Culture, bacterial; quantitative colony count, urine <1% 4,428 $14K
77067 Screening mammography, bilateral, including computer-aided detection <1% 451 $14K
76705 Ultrasound, abdominal, real time with image documentation; limited <1% 145 $13K
80061 Lipid panel <1% 931 $13K
84439 <1% 609 $12K
U0002 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc <1% 3,435 $12K
86900 <1% 578 $11K
59025 Fetal non-stress test <1% 62 $11K
86850 <1% 572 $10K
82306 Vitamin D; 25 hydroxy, includes fraction(s), if performed <1% 376 $10K
74018 <1% 285 $8K
72125 Computed tomography, cervical spine; without contrast material <1% 301 $8K
72100 <1% 250 $8K
86803 <1% 318 $8K
76805 Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation <1% 42 $7K
J3490 Unclassified drugs <1% 458 $7K
84702 <1% 457 $6K
83036 Hemoglobin; glycosylated (A1C) <1% 561 $6K
80320 <1% 420 $6K
81001 <1% 12,566 $6K
96367 <1% 94 $6K
73630 <1% 364 $5K
71250 <1% 72 $5K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 5,259 $4K
86703 <1% 96 $4K
73562 <1% 249 $4K
73030 <1% 213 $4K
87088 <1% 1,167 $4K
G0476 Infectious agent detection by nucleic acid (dna or rna); human papillomavirus (hpv), high-risk types (e.g., 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, 59, 68) for cervical cancer screening, must be performed in addition to pap test <1% 92 $4K
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 7,602 $4K
76642 <1% 28 $4K
73130 <1% 236 $3K
82607 <1% 193 $3K
86901 <1% 600 $3K
87340 <1% 132 $3K
87077 <1% 606 $3K
76830 Ultrasound, transvaginal <1% 102 $3K
87651 Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe <1% 2,045 $3K
85610 <1% 1,471 $3K
73610 <1% 261 $3K
96375 Therapeutic injection; each additional sequential IV push <1% 3,543 $3K
86140 <1% 2,070 $2K
12001 <1% 12 $2K
83735 <1% 1,634 $2K
80143 <1% 490 $2K
83605 <1% 1,396 $2K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 226 $2K
G0475 Hiv antigen/antibody, combination assay, screening <1% 97 $2K
87186 <1% 545 $2K
86780 <1% 91 $2K
J0500 Injection, dicyclomine hcl, up to 20 mg <1% 102 $2K
83540 <1% 155 $2K
83550 <1% 117 $2K
83690 <1% 4,419 $2K
73110 <1% 124 $2K
82077 <1% 274 $2K
81025 <1% 2,692 $2K
72040 <1% 30 $1K
93971 <1% 15 $1K
83880 <1% 659 $1K
76536 <1% 12 $1K
86762 <1% 54 $1K
87081 <1% 1,201 $1K
87040 <1% 812 $1K
90715 <1% 73 $1K
86592 <1% 72 $1K
80179 <1% 472 $1K
87624 Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types <1% 29 $1K
82150 <1% 2,429 $1K
82947 <1% 1,037 $1K
85379 <1% 1,737 $986.63
97161 <1% 14 $904.29
82248 <1% 839 $862.82
80076 <1% 290 $851.49
82728 <1% 48 $826.99
88305 Level IV - Surgical pathology, gross and microscopic examination <1% 65 $740.89
J8540 Dexamethasone, oral, 0.25 mg <1% 691 $738.60
J7030 Infusion, normal saline solution , 1000 cc <1% 4,696 $641.87
96376 <1% 392 $617.82
87880 Infectious agent antigen detection by immunoassay; Streptococcus, group A <1% 1,761 $588.79
82746 <1% 48 $570.12
82570 <1% 65 $503.41
87634 <1% 196 $439.15
84144 <1% 19 $418.70
82803 <1% 363 $398.72
J1100 Injection, dexamethasone sodium phosphate, 1 mg <1% 953 $315.41
85652 <1% 57 $305.66
81003 <1% 1,002 $294.44
80305 <1% 69 $293.36
85730 <1% 1,163 $232.19
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 4,943 $224.46
87070 <1% 31 $183.45
J7120 Ringers lactate infusion, up to 1000 cc <1% 822 $179.20
J1170 Injection, hydromorphone, up to 4 mg <1% 694 $173.02
73502 <1% 12 $171.45
J2270 Injection, morphine sulfate, up to 10 mg <1% 648 $144.90
84100 <1% 76 $122.22
J2360 Injection, orphenadrine citrate, up to 60 mg <1% 454 $122.03
73080 <1% 17 $81.59
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 985 $76.88
84703 <1% 80 $74.76
84156 <1% 19 $66.32
J2550 Injection, promethazine hcl, up to 50 mg <1% 246 $63.24
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 421 $31.66
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 2,332 $30.32
J3475 Injection, magnesium sulfate, per 500 mg <1% 14 $26.88
J2704 Injection, propofol, 10 mg <1% 570 $22.73
J7040 Infusion, normal saline solution, sterile (500 ml = 1 unit) <1% 427 $22.46
90471 Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine <1% 100 $20.47
J7620 Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme <1% 170 $19.48
J2272 Injection, morphine sulfate (fresenius kabi), not therapeutically equivalent to j2270, up to 10 mg <1% 15 $14.90
J3010 Injection, fentanyl citrate, 0.1 mg <1% 480 $10.57
J7050 Infusion, normal saline solution, 250 cc <1% 148 $7.44
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 324 $6.60
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 283 $6.03
J2765 Injection, metoclopramide hcl, up to 10 mg <1% 185 $5.90
J1650 Injection, enoxaparin sodium, 10 mg <1% 41 $2.72
J7512 Prednisone, immediate release or delayed release, oral, 1 mg <1% 353 $2.72
J2060 Injection, lorazepam, 2 mg <1% 31 $0.91
J7510 Prednisolone oral, per 5 mg <1% 75 $0.26
J0665 Injection, bupivicaine, not otherwise specified, 0.5 mg 0% 90 $0.00
97116 0% 15 $0.00
J2930 Injection, methylprednisolone sodium succinate, up to 125 mg 0% 69 $0.00
C1713 Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) 0% 20 $0.00
94664 0% 19 $0.00
87807 0% 41 $0.00
J0690 Injection, cefazolin sodium, 500 mg 0% 51 $0.00
94760 0% 21 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialGILLESPIE, NICKI (CFO)